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Circulating polymorphonuclear leukocytes (PMN)' exhibit negligible binding
affinity forunstimulated vascular endothelium (EC) . After intravenous administra-
tion ofachemotactic factor such as C5a, PMN attach to EC as evidencedby arapid
(<1 min) neuropenia (1, 2), but they soon detach and normal levels of circulating
PMN arerestored in 15-20 min . ThusPMN possess the means oftransiently making
then breaking adhesions to EC . Transient adhesion ofPMN to EC appears neces-
sary for extravasation in response toachemotactic signal .Agradient ofchemotactic
agent emanating from the surrounding tissues causes PMN first to bind to the lu
minal surface of the EC, then to break that adhesion as they move out ofthe vascular
space .
There is strong evidence that members of the CD11/CD18 complex of leukocyte
receptors mediate adhesion of stimulatedPMN to unstimulated EC . mAbs against
CDll/CD18 block adhesion ofPMN to EC both in vitro (3, 4) and in vivo (5, 6) .
In addition, PMN from patients deficient in CDll/CD18 fail to adhere to EC both
in vitro (3) and in vivo (7) . TheCDll/CD18 molecules are ideal candidates for medi-
ating transient adhesion ofPMN to EC in vivo, because their capacity to bind ligands
in vitro can be transiently enabled . CD11b/CD18, the most abundant member of
the CD11/CD18 complex on PMN, functions as a receptor for surface-bound C3bi
(8) . We have previously shown that the ability of this receptor to bind to erythro-
cytes coated with C3bi is dramatically stimulated by phorbol esters and that this
stimulation is short in duration (9) . Here show that CDll/CD18-dependent adhe-
sion of phorbol-treated PMN to EC increases and subsequently decreases with a
time course identical with that shown for the effect of phorbol esters on the binding
activity ofCDllb/CD18 for C3bi . We further show that adhesion ofPMN to EC
may be transiently stimulated with the physiological mediators TNF or C5a .
Expression ofCDllb/CD18 on the surface ofPMN is increased upon stimulation
with chemotactic factors (9-11) . We found that cytoplasts, which are depleted of in-
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tracellular pools of CDllb/CD18, exhibited the same transient adhesion to EC as
whole PMN. Thus, changes in expression of CD18 are not necessary for either the
initial increase or the subsequent decrease in CD18-dependent adhesion .
Materials and Methods
Reagents.
￿
Recombinant human TNF was a gift of Dr. A. Cerami (The Rockefeller Uni-
versity). TNF was stored sterilely at 4'C before use. Human recombinant complement frag-
ment C5a was a gift of Dr. M. Springer (Merck Research Laboratories, Rahway, NJ) and
was dissolved in HAP buffer (Dulbeccds PBS containing 0.5 mg/ml human serum albumin,
3 mM glucose, and 0.3 U/ml aprotinin) that contained (10-4 M) Plumber's inhibitor (DL-
2-mercaptomethyl-3-guanidinoethyl-thiopropanoic acid; CalBiochem-Behring Corp., San
Diego, CA) to inhibit the activity of carboxypeptidases. Phorbol dibutyrate (PDB) was ob-
tained from Sigma Chemical Co. (St. Louis, MO). Collagenase was purchased from Wor-
thington Biochemical Corp. (Freehold, NJ). Human fibronectin was supplied from the New
York Blood Center (New York, NY).
Monoclonal Antibodies.
￿
mAb OKM10 (IgG2n), directed against CDllb (8), was a gift of
Dr. G. Goldstein, (Ortho Pharmaceuticals, Raritan, NJ); mAb TSl/22 (IgGI) against CD11a
(12) and TSl/18 (IgGI) directed against CD18 (13) were supplied by Dr. T. A. Springer (Har-
vard Medical School, Boston, MA); mAb LeuM5 (IgG2b) directed against CDllc (14) was
obtained from Dr. L. Lanier (Becton Dickinson and Co., Mountain View, CA). Anti-CD18
mAb IB4 (IgG2a) and Fab fragments of IB4 were as described (8). mAb 60.3 (IgG2a) directed
against CD18 (15) was a gift from Dr. J. Harlan (University of Washington, Seattle, WA).
Additional anti-CD18 reagents, mAbs H52, MHM23 (ascitic fluids) were provided by Dr.
J. Hildreth (Johns Hopkins University, Baltimore, MD). mAb 3G8 (IgGI) directed against
the low avidity Fc receptor of PMN (FcRIII, CD16) was as described (16).
Cells.
￿
Human PMN were purified from freshly drawn human blood on Ficoll-Hypaque
gradients as described (17). Isolated PMN were >99% pure as assessed by Wright's stained
cytocentrifuge preparations and >99% viable as assessed by exclusion of trypan blue. PMN
were fluorescently labeled with a hydrophobic fluorescent compound (1,1'-dioctadecyl-3,3,3',3'-
tetramethylindocarbocyanine perchlorate (DiI); Molecular Probes, Eugene, OR). Cells at
4-8 x 106 cells/ml were incubated with 50 lzg/ml DiI in HAP buffer for 10 min at O'C, un-
bound dye was removed by three washes with HAP buffer, and labeled PMN were resuspended
in Medium 199 (M199; Hazleton Research Products Inc., Denver, PA.) for the adhesion assay.
Labeled PMN bound and phagocytosed IgG- and C3bi-coated erythrocytes as well as unla-
beled PMN (data not shown), indicating that there was no loss of functional activity during
the labeling. There was no visible transfer of DiI from PMN to EC during adhesion assays
at coincubation times up to 60 min. Both spread and rounded PMN appeared very bright
and were easily visible.
PMN were also isolated from two children ofFrench Canadian origin who have been diag-
nosed as congenitally deficient in the CD11/CD18 complex (Detmers, P. A., S. D. Wright,
E. Olsen-Egbert, R. Adamowski, Z . Chad, L. G. Kabbash, and Z. A. Cohn, manuscript
in preparation). These cells were labeled with Dil as described above. EC were harvested
from veins of human umbilical cords using collagenase as previously described (18). Primary
EC cultures were maintained in M199 plus 20% human serum (heat inactivated). When EC
cultures became confluent monolayers, EC were harvested from 35-mm tissue culture plates
(Corning Glass Works, Corning, NY) by exposure to 0.025% trypsin plus 1 mM EDTA for
2-3 min. EC were resuspended in M199 plus 20% human serum and seeded onto Terasaki
plates (Miles Laboratories, Naperville, IL) at a cell density of 106 cells/ml. The Terasaki
plates were precoated with human fibronectin (50 lAg/ml) for 15 min at 37'C. EC were cul-
tured a further 2-3 d before use in adhesion assays. During this time a confluent monolayer
formed with characteristic cobblestone morphology (Fig. 1) . The cell junctions stained with
silver nitrate (data not shown), and previous studies indicate that the EC monolayers stain
positive for factor VIII-related antigen (18).
Adhesion of PMN to EC.
￿
Dil-labeled PMN (10 trl of 106 cells/ml) were added to twice-
washed EC monolayers. Preliminary studies indicated that this concentration maintainedLO ET AL.
￿
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EC in excess of PMN, and yielded consistent and quantifiable adherent PMN without dis-
rupting the EC during the assay. Adhesion was allowed to proceed for 15 min at 37°C, and
unbound PMN were removed by three washes with M199. Residual adherent PMN on EC
surfaces were counted manually on an inverted microscope(DiaphotTMD; Nikon Inc., Garden
City, NY) equipped for fluorescence using the filter IF535-550. Values of five replicateswere
averaged, and variations between replicates were small (<10%). The adhesion of maximally
stimulated PMN was very consistent from experiment to experiment, but the adhesion of
unstimulated PMN varied considerably. Thus, the enhancement of adhesion by stimulants
varied from 3 to 10-fold. The background binding observed in the absence of stimulants was
partially inhibitable with anti-CD18 mAb IB4.
In experiments where PMN were treated with PDB (300 ng/ml), TNF (0.66 nM), or C5a
(10-sM), Dil-labeled PMN were treated with agonists for various times at 37°C, washed
three times with HAP buffer, and resuspended in M199 before the adhesion assay. Prelimi-
nary experiments showed these concentrations of agonists yielded optimal enhancement of
adhesion of PMN to EC. Treatment of PMN with any of these agonists did not alter PMN
viability, as judged by exclusion of trypan blue.
In experiments using mAbs to inhibit adhesion, PMN were treated with PDB for 15 min
at 37°C, washed three times with HAP buffer, and incubated with various mAbs (10 wg/ml)
for 20 min at 0°C before the adhesion assay. mAbs were present with the PMN-EC coculture
throughout the assay.
Preparation andCharacterization ofPMNCytoplasts.
￿
Cytoplasts were prepared by centrifuging
cytochalasin B-treated PMN on a two-step Ficoll gradient exactly as described (19).
Cytochalasin B was removed by washing the cytoplasts five times with incubation medium
(138 mM NaCl, 2.7 mM KCI, 8.1 mM Na2HP04, 1.5 mM KH2PO4, 0.6 mM CaC12, 1.0
MM MgCl2, 5.5 mM glucose, and 0.5% (wt/vol) human albumin). The yield of the cytoplast
preparation was >98%. Cytoplasts were either used immediately or frozen with 20% DMSO
as described (19), and were used within a month.
To confirm that cytoplasts were free of granular constituents, the activities of several en-
zyme markers were assayed and compared with those ofwhole PMN (Table 1). ß-glucuronidase
(20), myeloperoxidase (21), vitamin 1312-binding protein (22), and alkaline phosphatase (23)
were assayed by standard procedures. The cytoplasts had about one-third of the activity of
alkaline phosphatase found in whole PMN (Table I), which is consistent with a report that
cytoplasts have a surface area about one-third as great as that of whole cells (19). Enzymatic
activity of granule constituents in our cytoplast preparation was <4% that of whole PMN,
confirming previous reports (19) that cytoplasts are deficient in both specific and azurophilic
granules. The absence of granules within cytoplasts was confirmed by electron microscopy
(not shown).
Expression of Cell Surface Antigens.
￿
Expression of CDllb/CD18 on the surface ofPMN and
TABLE I
Enzyme Marker Activities in PMNand Cytoplasts
PMN and cytoplasts were used at 107 cells/ml for the enzyme assays.
` The enzyme activity in cytoplasts divided by that in PMN.
Enzymes PMN Cytoplasts
Percent
activity`
Alkaline phosphatase
(plasma membrane) 4.1 x 10-3 U/ml 1 .2 x 10-3 U/m1 34
0-glucuronidase
(azurophil granule) 173 x 10-3 U/ml 8 x 10-3 U/ml 0.5
Myeloperoxidase
(azurophil granule) 92 x 10-7 M 3 x 10-7 M 3
Vitamin B12-binding
protein (specific granule) 5.9 ng/ml 0.1 ng/ml 21782
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cytoplasts was measured by flow cytometry. PMN or cytoplasts were labeled with 5 kg/ml
FITC-conjugated OKMI for 20 min at 0°C and analyzed with a Becton Dickinson FACScan
cell analyzer. Nonspecific fluorescence wasdetermined in parallel preparations incubated with
20-fold excess unlabeled OKMI. To measure the expression of CDl1a/CD18, cells were in-
cubated at 0°C for 20 min with 5 pg/ml TSl/22, washed, and incubated with 10,ug/ml FITC-
conjugated goat anti-mouse IgG (HyClone Laboratories Inc.). The intensity of fluorescence
was subsequently analyzed by FAGS.
The expression of CDllb/CD18 on cytoplasts stimulated with PDB (300 ng/ml for 15 min
at 37°C) was measured to determine if depletion of granules abolished intracellular storage
pools ofCDllb/CD18. Unlike intact PMN, cytoplasts did not exhibit any increase in the sur-
face expression of CDilb/CD18 upon PDB stimulation (Table II).
Results
Adhesion ofStimulation PMNto EC Is CD111CD18Dependent.
￿
DiI-labeled PMN were
used to assaythe adhesion ofunstimulated and PDB-stimulated PMN to EC. Without
stimulation, very few PMN bound to EC (Fig. 1 a and b). In contrast, when PMN
were treated with PDB (300 ng/ml) for 15 min at 37°C, increased numbers of ad-
herent PMN were observed (Fig. 1 c and d). Based on counts made before and after
washing, N50% of the added PMN bound to EC. PMN adhered as individuals rather
than aggregates, and the integrity of the EC monolayers was not altered during the
adhesion assay (Fig. 1 a and c).
The adhesion of PMN to EC observed in our assay is mediated entirely by the
CDII/CD18 complex on PMN. Treating PDB-stimulated PMN with mAb IB4 against
CD18 before the incubation with EC completely abrogated the adhesion of PMN
to EC (Fig. 2). Fab fragments of IB4 also had potent inhibitory activities, indicating
that the Fc portion of the mAb is not involved in the inhibition of PMN adhesion
(Fig. 3). Several other anti-CD18 mAbs (H52, MHM23, 60.3, and TSl/18) had a
similar potent inhibitory effect on binding ofPDB-stimulated PMN to EC, but con-
trol mAbs against other determinants on PMN were without inhibitoryeffects (Fig.
3, and see below). Further evidence for the role of CDII/CD18 in adhesion was de-
rived from studies on PMN from two patients with a genetic deficiency in CD11/CD18.
These cells failed to adhere to EC, even after stimulation with PDB (Fig. 2). These
results confirm the primacy of CDII/CD18 in adhesion to unstimulated EC and dem-
onstrate that our EC do not exhibit CDII/CD18-independent adhesion character-
istic of stimulated EC (4, 24).
CD11a/CD18 and CD11b/CD18, but not CD11c/CD18 Mediate Phorbol-enhanced PMN
Adhesion ofPMNtoEC. To determine which individual members of the CDII/CD18
complex were responsible for the adhesion of phorbol-treated PMN to EC, adhesion
TABLE II
FACS Analysis of CDIIb/CD18 Expression on Cytoplasts
Cytoplasts (106 cells/ml) were treated with PDB (300 ng/ml) for 15 min at 37°C,
washed, and stained with FITC-OKM1 (10 ug/ml) for 20 min on ice. Fluores-
cence was analyzed by flow cytometry.
Mean channel of fluorescence
Background 5
Unstimulated cytoplasts 777
PDB-stimulated cytoplasts 732FIGURE 1 .
￿
Adhesion of unstimulated PMN and PDB-stimulated PMN to EC . Unstimulated
PMN (A and B) or PDB-stimulated PMN (C andD) were incubated for 15 min at 37°C with
EC,then the monolayers were washed . (A and C) Phase contrast micrographs ; (B andD) respec-
tive fluorescent images showing DiI fluorescence from adherent PMN.1784
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was measured in the presence ofmAbs against CD11a, CD11b, orCD11c (see Materials
and Methods). mAb TSl/22 against CDlla and OKM10 against CD11b each in-
hibited binding ofstimulated PMN by -66% (Fig. 3). mAb LeuM5 against CD11c
caused no inhibition (Fig. 3). The inhibition caused by mAbs was unlikely to be
due to a steric effect sincemAb 3G8, directed against FcRIII onPMN, had virtually
no effect on adhesion(percent inhibition = 5%) (Fig. 3), and Fc receptors are more
abundant on the cell surface than CDllb/CD18 or CDlla/CD18 (9).
The inhibition of binding caused by anti-CD11a and CDllb was partial, yet the
inhibition by anti-CD18 was nearly complete (>90%), suggesting that CDlla/CD18
and CD11b/CD18 may both function in adhesion of stimulated PMN to EC. This
was confirmed by the observation that a mixture ofmAbs OKM10 and TS1/22 had
an additive inhibitory effect on adhesion (percent inhibition = 93%) (Fig. 3). The
combined inhibitory effect ofanti-CD11a and CD11b mAbswas similar to that achieved
byanti-CD18 mAbs (Fig. 3). Thesedatasuggestthat CDlla/CD18 and CDllb/CD18
FIGURE 2.
￿
CDll/CD18-dependent adhesion
of stimulated PMN to EC. The adhesion of
PMN from a normal donor andtwo CD18-
deficient patients wasassayed as described in
Materials and Methods. Where indicated,
PMNwere stimulated with 300 ng/ml PDB
for 15 min at 37'C before the assay. PDB-
treated PMN were treatedwith mAbIB4 as
described in Materials and Methods. These
data were confirmedby asecond experiment
that gave similar results.
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FIGURE 3.
￿
CDlla/CD18 andCDllb/CD18 butnotCDllc/CD18, mediatephorbol-enhanced adhe-
sion of PMN to EC. Dil-labeled PMNwere stimulated with 300 ng/mlPDBfor 15 min at 37'C,
treatedwith mAbas described in Materials and Methods, and adhesion to EC was assayed. The
data are means of five to seven experiments, and error bars indicate SEM.each mediate adhesion ofphorbol-stimulated PMN to EC, that each makes a com-
parable contribution, and that CD11c/CD18 makes very little ifany contribution to
adhesion.
The CapacityofCD11/CD18 toMediateAdhesion ofPMNtoECIs TransientlyStimulated
byPhorbolEsters. We previously showed that the capacity ofCD11b/CD18 on PMN
tobind to erythrocytes coated with complement fragment C3bi (EC3bi) is transiently
enhanced upon stimulation of the cells with phorbol esters (9). To determine if
CDll/CD18-dependent binding of PMN to EC is regulated in a similar fashion,
PMNwere incubatedforvariousintervalswith PDB at 37°C, then assayedforadhesion
to EC. The binding ofPMN to EC increased sharply after 15 min of stimulation
andthen fell below controllevels by 60min (Fig. 4). Thetime course ofthesechanges
inbinding activity wasidentical withthat for thebindingofEC3biby phorbol-treated
PMN (9). The loss ofbinding activity after 60 min of stimulation by PDB was not
caused by cell death, as >95To ofPMN excluded trypan blue after treatment with
PDB for 60 min. Furthermore, the loss ofadhesivity required active metabolism,
since PMN incubated with PDB for 15 min at 37°C retained high binding activity
to EC after a 1-h incubation at 4°C (data not shown).
TransientBindingActivity Inducedby PhysiologicalStimuli.
￿
It has been reported that
the physiological mediators TNF and C5a cause enhanced adhesion ofPMN to EC
(25, 26), and we next asked whether enhancement by these agents is also transient.
Pretreatment ofPMN with TNF (0.66 nM) caused a rise and subsequent fall in
binding activity with a time course similar to that seen with PDB (Fig. 4). C5a (10-8
M) also caused asimilar transient increase in bindingactivity (Fig. 5), but the peak
occurred before 15 min. Toaccuratelyfollow thetime course ofC5a-stimulatedadhe-
sivity, we added C5a (10-8 M) directly to cocultures ofPMN and EC and incubated
them for different times. C5a caused strong adhesion of PMN to EC as early as
2 min, and maximum adhesion was observed at 5 min. Adhesion of PMN to EC
returned to basal levels by 15-20 min (Fig. 5). The adhesion stimulated by both
C5a and TNF is CD11/CD18 dependent, since both were completely blocked by
treating PMN with soluble mAb IB4 (data not shown).
Detachment ofPMNfrom EC.
￿
Upon stimulation ofcells with C5a, PMN first ad-
hered to and then detached from the EC (Fig. 5). Since C5a-stimulated attachment
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FIGURE4.
￿
Transientenhance-
ment of PMN adhesion to EC
by phorbolor TNF Dil-labeled
PMN were stimulated with ei-
ther PDB (300 ng/ml) or TNF
(0.66 nM) forvarious times at
37°C. Agonists were removed
by three washes with HAP be-
fore the adhesion assay. Control
PMNwere incubatedfor15 min
at 37°C in the absenceof ago-
nists. Theexperiment is repre-
sentative of three separate ex-
periments.1786
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to EC was mediated by CD11/CD18, we presume the subsequent detachment was
associated with release ofligand by these adhesive receptors. It is unlikely that re-
lease is due to an irreversible process such as proteolysis of receptors or ligands be-
cause adhesioncouldbe rapidly reestablished byrestimulation ofthecells. Adhesion
ofPMN was initiated by stimulation ofcells for 5 min with C5a (10'8 M). Nonad-
herent cells were removed by washing, and during a subsequent 15 min at 37'C,
the PMN were observed to detach (Fig. 6). Restimulation ofthe detached cells for
5 min with PDB (300 ng/ml) or TNF (0.66 nM) caused rebinding ofPMN to EC.
In contrast, C5a restimulation did not cause the detached PMN to re-adhereto EC.
The second enhancement in PMN adhesion was also CD11/CD18 dependent since
it was blocked by mAb IB4 (data not shown).
Regulation ofBinding ofPMN to EC Does Not Correlate with Changes in Expression of
CD11a/CD18andCD11b/CD18. Todetermine whethertheincrease and subsequent
decrease in CDll/CD18-dependentbinding ofPMN to EC was associated wtih quan-
FIGURE 6. Restimulation of
C5a-stimulated adhesion of
PMNto EC. PMNwere layered
on EC and exposed to C5a
(10-8 M) for 5 min at 37°C by
whichtime theability ofPMN
to adhere to EC had reached
maximum (see Fig. 5). Un-
bound PMN were removedb
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wasthen addedto thePMN-EC
cocultures, and adhesion was allowed to continue for an additional 5 min at 37°C. Adherent PMN
were scored afternonadherent PMNwere removed by three washes with M199. Theexperiment shown
here is representative ofthreeseparate experiments. Errorbars indicate thestandard deviation ofthemean.
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(5.)titative changes in the cell surface receptors, the expression of CD11a/CD18 and
CD11b/CD18 on PMN stimulatedwith agonists fordifferentlengthsoftimewasmea-
sured by flow cytometry.
CDIIa/CD18.
￿
Treatment of PMN with PDB (300 ng/ml) caused little change
in the expression in CD11/a/CD18 at any time from 0 to 60 min (Fig. 7). Similarly,
neither TNF nor C5a caused changes in the expression ofCD11a/CD18 on the cell
surface (data notshown). These dataconfirm the observations ofother investigators
(9, 27) who showed that CDlla/CDl8 expression is not changed upon stimulation
ofPMN. Phorbol-stimulated changes in adhesion ofPMN toEC cannot, therefore,
be accounted for by changes in the number of CDlla/CD18.
CD1Ib/CD18.
￿
PDB (300 ng/ml) caused a rapid 2.7-fold increase in the expres-
sion ofCD11b/CD18 that reached maximum at 15 min and remained at above two-
fold for 60 min (Fig. 7). Whilethe timecourse ofthe increasedexpression was com-
parable to that for increased adhesion, this change in expression is insufficient to
explain the transient changes in adhesivity. The 2-3-fold increase in CD11/CD18
expression ismuch less thanthe 3-10-foldincrease inadhesion observed after 15 min
of stimulation. More importantly, expression of CDllb/CD18 remained high for
60min, during which time the capacity ofPMNto bind to EC fellto baseline levels.
PMN treated with TNF (0.66 nM) exhibited a rapid and sustained rise in the
expression of CDllb/CD18, with a time course differing from that of the binding
activity (Fig. 8). An increase in the expression of CD11b/CD18 was also observed
when PMN were treated with C5a (10-8 M) (Fig. 8). Although the initial rate of
increase was similar to that seen with TNF, the maximum expression by 10-15 min
was lowerthan withTNF, and the amount ofCD11b/CD18 on thecell surfacesubse-
quently declined to thatobservedbefore stimulation. For treatment with either TNF
ofC5a, the time course ofchange in the expression ofCDllb/CD18 does not corre-
late well with that for changes in binding activity. These observations suggest that
changes in the expression ofCDllb/CD18 on the cell surface may contribute to the
transient enhancement ofbinding activity but do not provide a complete explana-
tion for this phenomenon.
CytoplastsBind Transiently toEC.
￿
Totest thehypothesis that amechanism unrelated
to changes in the expresssion of CDllb/CD18 functions to regulate attachment of
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FIGURE 7. Expression of
CDlla/CD18 and CDllb/CD18
on thecell surfaceofPMNupon
stimulation with PDB. PMN
were treatedwith PDB (300 ng/
ml) at 37°C for the indicated
times, then stained with FITC-
mAb TS1/22 or OKMI as de-
scribedin MaterialsandMeth-
ods. Sinceeach experiment had
a differentbaselines mean chan-
nelof fluorescence, the percent
change in mean channel offluo-
rescence wasused to more accu-
rately reflect thechanges. Data
shown represent the means of
threeexperiments, andtheerror
bars indicate the SEM.1788
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FIGURE 8. CDllb/CD18 ex-
pression induced by TNF and
C5a. PMN were treated with
TNF (0.66 nM) or C5a (10-8
M) for the indicated times at
37°C and stained with FITC-
OKMI as described in Mate-
rials and Methods. The data
represent the means ofthreeex-
periments, and the error bars
indicate the SEM. Parallel
studieson CDlla/CD18 showed
that neither TNF nor C5a
changed expression (<157o
change from baseline at any
time point).
PMN toEC, weemployedcytoplasts, which are depleted ofthe intracellulargranules
that act as storage pools ofCD11b/CD18 . Flow cytometry was used to measure the
expression ofCDllb/CD18 on the surface of cytoplasts treated with PDB, and no
significant increase was observed at times up to 60 min (Fig. 9). Resting cytoplasts
bound poorly to EC, but stimulation for 15 min with PDB caused a fourfold en-
hancement in binding. Further incubation with PDB caused binding to return to
baseline levels by 60 min. Thus transient changes in the adhesion capacity of
CD11/CD18mayoccur in the absence ofalteration in the surface expression ofthese
molecules and in the absence of granule contents.
Discussion
Adhesion ofPMNto EC IsMediatedby TwoMembersofthe CD111CD18 Complex.
￿
Es-
sentially all of the adhesion of stimulated PMN to unstimulated EC we observed
inourassay wasdependent onCD11/CD18 moleculeson the PMN. Anti-CD18mAbs
blocked adhesioncompletely, and PMN from CD11/CD18 deficient patientsdid not
adhere (Fig. 2). However, other mechanisms for adherence ofPMN to EC do exist.LO ET AL.
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Severallaboratories have shown that stimulation ofEC for several hours witheither
LPS, IL-1, or TNF results in strong adherence of PMN that does not require
CD11/CD18 expression (24, 28, 29). Wehave alsoobserved CD11/CD18-independent
adhesion on EC stimulated with TNF for 3 h (unpublished observations). These
observations confirm that our EC are sensitive to stimulation and our assay can de-
tect adhesionsmediated by other mechanisms, but that these othermechanisms are
not operative in our experiments. Our EC thus resemble naive, unstimulated EC,
and our system best models the rapid (1-15 min) binding of PMN to EC observed
after the introduction ofan inflammatory stimulus into tissues in vivo. The rapid
timecourse ofaction ofthe stimuli used (PMA, TNF, C5a)is consonant withthisview.
The adherence of maximally stimulated PMN appears to use CDlla/CD18 and
CD11b/CD18 to anapproximately equal degree. Antibodies againstCD11a and CD11b
inhibited binding to a similar extent (6670) and a combination of anti-CDlla and
anti-CD11b completely blocked binding (Fig. 3). CD11c/CD18, on the other hand,
did not appear to contribute to the adhesion measured here. It is not clear whether
this reflects an intrinsic inability ofCDllc/CD18 to mediate adhesion to EC or if
it reflects the source ofendothelial cells:Nhile CD11a/CD18 is known to recognize
the molecule ICAM-1 (30, 31), the identity of the ligands on EC recognized by
CDllb/CD18 is not known. It isalso not knownwhetherCD11b/CD~8 or CD11c/CD18
can recognize ICAM-1.
Relationship of TransientAdhesion to PMNFunctionIn Viva
￿
The abilityofCD11/CD18
to mediate bindingto EC was transiently stimulated by PMA, TNF, and C5a. Max-
imal binding in response to C5a occurred after 5 min of stimulation but receded
to baseline levels after 15 min (Fig. 5). This response mirrors the rapid, transient
neutropenia observed in animals injected intravenously with C5a (1, 2). A slower
time course of adhesion was observed for PMN treated with PMA and TNF, with
maximal binding after 15 min and a return to baseline adhesion by 60 min. These
times correspond well with the transient neutropenia observed in rabbits injected
intravenously with TNF (32).
Transient adhesion ofPMN to EC may representanimportant aspect oftransen-
dothelial migration ofPMN in vivo. PMN extravasting in response to a spatial gra-
dient ofchemoattractant diapedese by forming new adhesion at the leading front
whilesimultaneouslybreakingadhesions in theuropod region. The enhanced binding
of PMN to EC observed in the response to a temporal gradient of stimulant may
be relatedto the formationofnewadhesionsattheleadingedge ofa migratingPMN,
while lossofadhesivity afterlonger timesofincubation in stimulant may correspond
to detachment of the uropod from the substrate. The adhesion ofa migrating cell
is ofnecessity transient, andwe suggest that the CD11/CD18 molecules maymediate
this transient adhesion.
Previous studies from this laboratory (9) showed thatphorbol esters cause a tran-
sient change in the capacity ofCD11b/CD18 to bind toC3bi-coatederythrocytes with
a time course and magnitude identical with that shown here for adhesion to EC.
These observations thussuggestthat thebindingsite on CD11b/CD18 forEC isregu-
lated in the same way as the binding site for C3bi. Since both CD11a/CD18 and
CDllb/CD18 contribute to adhesion, these observations also suggest that not only
CD11b/CD18but also CD11a/CD18 is regulatedin a transientfashion by phorbolesters.
Mechanism ofInducedCD18 Function.
￿
Stimuli thatenhance adhesion ofPMN also1790
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cause an increase in the expression of CDllb/CD18 molecules on the cell surface
(9, 10, 11; Figs. 7 and 8). However, several observations suggest that this change in
CD11b/CD18 expression cannot fully explain the changes observed in adhesivity.
Phorbol esters caused no increase in CD11a/CD18 and only a three-fold increase
in CDllb/CD18 expression, but adhesion to EC increasedas much as 10-fold. More
importantly, expression ofCDllb/CD18 remainedhigh during the subsequentdrop
in adhesivity (Figs. 4 and 7). Thus, an additional mechanism unrelated to changes
in surface expression may be at work to control CD11b/CD18-dependent adhesion.
Theexistence ofsuchamechansism is confirmedbyobservations oncytoplasts. These
cell fragmentsdid not alterexpression ofCDllb/CD18 molecules in response to stim-
ulation with phorbol because they lacked intracellular pools of receptor (Tables I
and II, Fig. 9), yet they showed a rise and fall in adhesivity to EC in response to
phorbol esters with a time course similar to that of whole cells. Thus changes in
expression of CD18 are not necessary for either the initial rise or subsequent fall
in CD18 function. Weconclude thatqualitativechanges in existingreceptors appear
to be necessary and sufficient to control CD18-dependent adhesion. Alteration in
surface expression of CDllb/CD18 may contribute to changes in adhesivity but a
clear role for this phenomenon has yet to be determined.
Other studies haveexplored theinitial rise in CD18-dependent adhesivity ofPMN
caused by chemotactic stimuli. Changes in the number of CD18 molecules on the
cell surface were found not to correlate with enhanced aggregation of PMN (33),
enhancedbindingofC3bi-coated particles (9), or enhanced bindingto endothelium
(34). Our results confirm these findings, and extend them by showing that C1318-
dependent adhesion of PMN to endothelium is transient, and that the decline in
binding is not dependent upon changes in the number of CD18 molecules on the
cell surface.
What is the nature ofthe qualitative change(s) in CD11/CD18? Proteolysis ofcell
surface receptors appears unlikely to participate since immunoprecipitation experi-
ments showed no evidence ofproteolysis ofCD11/CD18 accompanying lossofreceptor
activity (Lo, S. K., and S. D. Wright, unpublished observation), and PMN treated
with C5a until theywere nolonger adherent were able to readhere when stimulated
subsequently with PMA or TNF (Fig. 6). The action of lytic enzymes contained
within granules is also unlikelyto contributesince granule-free cytoplasts shownormal
transient binding behavior. An alternative explanation is suggested by the recent
work of Detmers et al. (35), who found that CDllb/CD18 aggregates in the plane
ofthe membrane in response to stimuli that enhance its bindingcapacity, and that
aggregation is a prerequisite for binding. The time course of enhanced binding of
PMN to EC (Fig. 4) and the CDllb/CD18-dependent bindingofC3bi-coated erythro-
cytes to PMN (9). It is thus possible that stimulation ofPMN leads to aggregation
of CD11/CD18 molecules, and that the aggregates mediate adhesion to EC.
Summary
Fluorescently labeled polymorphonuclear leukocytes (PMN) were used to mea-
sure adhesion tohuman umbilicalveinendothelialcells(EC) cultured in vitro. Stim-
ulation of PMN with phorbol dibutyrate (PDB), TNF, or C5a caused an increase
in adhesion followed by a return to prestimulation levels ofadhesion oflonger times
ofincubation. Maximal adhesion of PMN to EC occurred rapidly in response toLO ET AL.
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C5a (5 min) and more slowly with TNF or PDB (15 min) . PMN stimulated to ad-
here with C5a detached from EC by 15 min.
PMN from CD11/CD18-deficient patients and PMN incubated with anti-CD18
mAbs failed to bind to EC despite maximal stimulation. Anti-CDlla/CD18 and anti-
CDl1b/CD18 each partially inhibited adhesion, and a combination of these two re-
agents completely blocked adhesion. The adhesion we measured was therefore com-
pletely dependent on CDll/CD18, and CDlla/CD18and CDllb/CD18each contributed
to adhesion. Stimuli that enhanced adhesion of PMN to EC also enhanced expres-
sion ofCD11b/CD18 on the cell surface, but the time course of expression correlated
poorly with changes in adhesivity. To determine if changes in the expression of
CDllb/CD18 are necessary for the changes in adhesivity, we used enucleate cytoplasts
that did not increase expression of CDllb/CD18. Cytoplasts showed a normal rise
and fall in adhesivity in response to PDB. We conclude that the transient adhesion
of stimulated PMN to naive EC is regulated by changes in the nature of existing
CD11/CD18 molecules on the PMN surface. Changes in expression of CDllb/CD18
may contributeto enhancement ofadhesivity, but a definite role for this phenomenon
has yet to be established.
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